Figures & data
Figure 1. Mathematical model [Citation5,Citation6] based prediction on the impact of implementing human papillomavirus (HPV) vaccination with 80% coverage according to the girls-only (a and b) vs. gender-neutral (c and d) strategy on HPV16 incidence in women (left) and men (right) by age and calendar time (years).
![Figure 1. Mathematical model [Citation5,Citation6] based prediction on the impact of implementing human papillomavirus (HPV) vaccination with 80% coverage according to the girls-only (a and b) vs. gender-neutral (c and d) strategy on HPV16 incidence in women (left) and men (right) by age and calendar time (years).](/cms/asset/17a90ba4-c9a9-46d4-8b82-0d4df4a44e10/ierv_a_2064279_f0001_oc.jpg)
Figure 2. Incidence of invasive cervical cancer (/100,000 women) in Finnish fertile-aged women (<40 years of age) during 1953–2018 (NORDCAN 2.0 https://nordcan.iarc.fr/en/ Database version 9.0 accessed on 11/07/202 [Citation21]). The red dotted line indicates the cervical cancer elimination threshold specified by the WHO. The blue dots indicate the observed crude rate of each year.
![Figure 2. Incidence of invasive cervical cancer (/100,000 women) in Finnish fertile-aged women (<40 years of age) during 1953–2018 (NORDCAN 2.0 https://nordcan.iarc.fr/en/ Database version 9.0 accessed on 11/07/202 [Citation21]). The red dotted line indicates the cervical cancer elimination threshold specified by the WHO. The blue dots indicate the observed crude rate of each year.](/cms/asset/4baa5fb9-12e3-419d-a7ee-540d9954383a/ierv_a_2064279_f0002_oc.jpg)
Table 1. Incidence (age-specific incidence rates per 100,000 women) of cervical cancer in 20–39-year-old Finnish women over 60 years (NORDCAN)